Martine Rothblatt has one message for United Therapeutics Corp. (NASDAQ: UTHR) investors: She has high expectations for 2020. “Frankly, we have never had a greater prospective news flow for United Therapeutics than we do in the next 12 months,” said Rothblatt, the Silver Spring biotech’s founder and CEO, on a quarterly earnings call Wednesday. The company expects “no fewer” than three approvals from the Food and Drug Administration next year, Rothblatt said. Those on deck for commercialization…
from https://www.bizjournals.com/baltimore/news/2019/10/31/united-therapeutics-2020-plan-no-fewer-than-3-fda.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/188727538617
No comments:
Post a Comment